Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
Available as: 200 mg/20 ml · 1 x 5

Indications & Uses

Lipuro is used for the induction and maintenance of general anaesthesia, for sedation during intensive care, and for sedation during surgical and diagnostic procedures.

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Dosage for Adults Induction of general anaesthesia: The dose of Propofol should be adjusted for each patient based on how they respond. The usual starting dose in adults is 40 mg (4 ml) given by slow intravenous bolus injection at intervals of 10 seconds, continued until clinical signs show that anaesthesia has begun. The usual induction dose in a healthy patient under 55 years of age is 2.2 to 2.5 mg/kg. A dose of 1.0 to 1.5 mg/kg is often enough for an older patient. Lower doses, most often 20 mg (2 ml) at intervals of 10 seconds, are recommended for patients of ASA grades 3 and 4. Maintenance of general anaesthesia: Anaesthesia can be maintained by giving Propofol either as a continuous infusion or as repeated bolus injections to keep the patient sufficiently anaesthetised. For continuous infusion, the rate needed varies considerably from patient to patient. At the start of anaesthesia, roughly during the first 10 to 20 minutes, some patients may need a slightly higher infusion rate of 8 to 10 mg/kg/h. However, sufficient anaesthesia is normally achieved with an infusion of 4 to 6 mg/kg/h, and sometimes up to 12 mg/kg/h. For repeated bolus injections, doses of 25 to 50 mg (2.5 to 5.0 ml) can be given depending on the patient's response. Sedation during intensive care: A bolus injection of 1.0 to 2.0 mg/kg should be given first, followed by a continuous infusion adjusted to the degree of sedation required. An infusion rate of 0.3 to 4 mg/kg/h is usually enough. Sedation for surgical and diagnostic procedures: Doses should be adjusted for each patient. Sufficient sedation for surgical and diagnostic procedures can usually be achieved by giving an initial dose of 0.5 to 1 mg/kg over 1 to 5 minutes, then maintaining sedation with a continuous infusion at a rate of 1 to 4.5 mg/kg/h. A bolus dose of 10 to 20 mg can be given in addition if deeper sedation is suddenly needed. Lower doses of Propofol are often enough for patients of ASA grades 3 and 4, and for older patients. Children: Propofol is not recommended for children under 3 years of age, as its safety has not been demonstrated in this age group. Induction of general anaesthesia: The dose of Propofol in children should be adjusted for weight and age. The average induction dose in children over 8 years is 2.5 mg/kg, given by slow intravenous injection until clinical signs show that anaesthesia has begun. Younger children may need slightly higher doses of Propofol per kilogram of body weight. Lower doses are recommended for children of ASA grades 3 and 4. Maintenance of general anaesthesia: Anaesthesia can be maintained by giving Propofol either as a continuous infusion or as repeated bolus injections. The dose should be adjusted for each child, but an infusion rate of 9 to 15 mg/kg/h is usually enough to achieve satisfactory anaesthesia. Sedation during intensive care and for surgical or diagnostic procedures: Propofol is not recommended for sedation in children, as its effectiveness and safety have not been demonstrated for this use. Although no causal link has been established, serious adverse events, including deaths, have been reported in cases where Propofol was used against these recommendations. Adverse events have most commonly been seen in children with respiratory tract infections who were given doses higher than those recommended for adults.

Side Effects

Local: Lipuro is usually well tolerated. The most common side effect is pain at the injection site, which can be lessened by mixing the preparation with lidocaine or by injecting into one of the larger veins of the forearm or the crook of the elbow. Thrombosis and phlebitis are uncommon. General: Low blood pressure and a brief pause in breathing can occur when anaesthesia is induced, and these effects may be pronounced in patients who are already in poor general health. Epileptic-type movements, convulsions, and dystonic reactions have been seen, though rarely. Fluid in the lungs (pulmonary oedema) has also been reported. Headache, nausea, and, less commonly, vomiting may occur in some patients on recovery, which may also come with a further brief spell of clouded consciousness. Hypersensitivity reactions have been reported in some cases, presenting with anaphylactic-type symptoms such as marked low blood pressure, bronchospasm, swelling, and facial redness. Cardiac arrest has occurred in some cases linked to Lipuro's use. With long-term use, urine may turn green or reddish-brown; this is due to Lipuro's quinol metabolites and is not harmful. As with other anaesthetics, changes in sexual behaviour may occur.

Cautions & Contraindications

Warnings & Precautions

Lipuro should only be given by specialists in anaesthesiology or under their supervision. The physician performing a surgical or diagnostic procedure should not administer Lipuro. Facilities for resuscitation in case of any complication should be available at the treatment unit. During administration of Lipuro, patients shall be monitored continuously so that possible hypotension, obstruction in the respiratory tract, hypoventilation or insufficient oxygen intake can be picked up at a sufficiently early stage. Special attention shall be paid to patients sedated by Lipuro for a surgical or diagnostic procedure who are not artificially ventilated. Caution shall be taken in administering Lipuro to patients with cardiac, respiratory, renal or hepatic insufficiency. Hypovolemic patients and those in poor general condition form another risk group. Since Lipuro lacks vagolytic activity, bradycardia, even asystole, may occur. Intravenous administration of an anticholinergic agent before induction and during maintenance of anaesthesia should be considered, especially if Lipuro is used together with other agents likely to cause bradycardia, and in situations where vagal tone is likely to predominate. Since Lipuro is a lipid emulsion, appropriate care should be applied in patients with severe disorders of fat metabolism such as pathological hyperlipidemia. If Lipuro is given to a patient for whom excessive fat intake may be risky, blood lipid values shall be monitored and the Lipuro dosage decreased if necessary. If the patient is also receiving other parenteral lipid emulsions besides Lipuro, the amount of lipid in Lipuro (0.1 g/ml) shall be taken into account when calculating total fat intake. In epileptic patients, Lipuro may lead to convulsions. The analgesic effect of Lipuro on its own is insufficient, so analgesics shall be used to ensure adequate pain relief. Full recovery from general anaesthesia shall be confirmed before discharge. It should be noted that the aftermath of general anaesthesia may impair the patient's ability to understand instructions given after the procedure.

Contraindications

Allergy to propofol or any other ingredient in the preparation.

Drug Interactions

Open checker →
Last updated: 20 Aug 2026